PIK3CD and Hyperinsulinemia: When inhibited, blood glucose levels increase, causing hyperinsulinemia that stimulates IRS1, contributing to activating the PI3K/AKT pathway and possibly representing a mechanism of resistance to anti-PI3K drugs.